These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 19215943

  • 21. Prevalence of germline mutations in patients with pheochromocytoma or abdominal paraganglioma and sporadic presentation: a population-based study in Western Sweden.
    Muth A, Abel F, Jansson S, Nilsson O, Ahlman H, Wängberg B.
    World J Surg; 2012 Jun; 36(6):1389-94. PubMed ID: 22270996
    [Abstract] [Full Text] [Related]

  • 22. Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma.
    Cascón A, López-Jiménez E, Landa I, Leskelä S, Leandro-García LJ, Maliszewska A, Letón R, de la Vega L, García-Barcina MJ, Sanabria C, Alvarez-Escolá C, Rodríguez-Antona C, Robledo M.
    Horm Metab Res; 2009 Sep; 41(9):672-5. PubMed ID: 19343621
    [Abstract] [Full Text] [Related]

  • 23. A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma.
    D'Elia AV, Grimaldi F, Pizzolitto S, De Maglio G, Bregant E, Passon N, Franzoni A, Verrienti A, Tamburrano G, Durante C, Filetti S, Fogolari F, Russo D, Damante G.
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):391-7. PubMed ID: 22946750
    [Abstract] [Full Text] [Related]

  • 24. Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD.
    Dannenberg H, van Nederveen FH, Abbou M, Verhofstad AA, Komminoth P, de Krijger RR, Dinjens WN.
    J Clin Oncol; 2005 Mar 20; 23(9):1894-901. PubMed ID: 15774781
    [Abstract] [Full Text] [Related]

  • 25. Risk-oriented approach to hereditary adrenal pheochromocytoma.
    Machens A, Brauckhoff M, Gimm O, Dralle H.
    Ann N Y Acad Sci; 2006 Aug 20; 1073():417-28. PubMed ID: 17102110
    [Abstract] [Full Text] [Related]

  • 26. Transcription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas.
    Dahia PL, Familial Pheochromocytoma Consortium.
    Ann N Y Acad Sci; 2006 Aug 20; 1073():208-20. PubMed ID: 17102089
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
    Astuti D, Hart-Holden N, Latif F, Lalloo F, Black GC, Lim C, Moran A, Grossman AB, Hodgson SV, Freemont A, Ramsden R, Eng C, Evans DG, Maher ER.
    Clin Endocrinol (Oxf); 2003 Dec 20; 59(6):728-33. PubMed ID: 14974914
    [Abstract] [Full Text] [Related]

  • 29. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC, Williams R, Blair E, Devilee P, Taschner PE.
    BMC Med Genet; 2006 Jan 11; 7():1. PubMed ID: 16405730
    [Abstract] [Full Text] [Related]

  • 30. Three novel VHL germline mutations in Korean patients with von Hippel-Lindau disease and pheochromocytomas.
    Kang HC, Kim IJ, Park JH, Shin Y, Jang SG, Ahn SA, Park HW, Lim SK, Oh SK, Kim DJ, Lee KW, Choi YS, Park YJ, Lee MR, Kim DW, Park JG.
    Oncol Rep; 2005 Oct 11; 14(4):879-83. PubMed ID: 16142346
    [Abstract] [Full Text] [Related]

  • 31. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
    Pollard PJ, El-Bahrawy M, Poulsom R, Elia G, Killick P, Kelly G, Hunt T, Jeffery R, Seedhar P, Barwell J, Latif F, Gleeson MJ, Hodgson SV, Stamp GW, Tomlinson IP, Maher ER.
    J Clin Endocrinol Metab; 2006 Nov 11; 91(11):4593-8. PubMed ID: 16954163
    [Abstract] [Full Text] [Related]

  • 32. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A, Rao JU, Lenders JW, Pellegata NS, Kusters B, Piscaer I, Hermus AR, Plantinga TS, Langenhuijsen JF, Vriens D, Janssen MJ, Gotthardt M, Timmers HJ.
    J Nucl Med; 2015 Jun 11; 56(6):839-46. PubMed ID: 25883126
    [Abstract] [Full Text] [Related]

  • 33. Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
    Srirangalingam U, Khoo B, Walker L, MacDonald F, Skelly RH, George E, Spooner D, Johnston LB, Monson JP, Grossman AB, Drake WM, Akker SA, Pollard PJ, Plowman N, Avril N, Berney DM, Burrin JM, Reznek RH, Kumar VK, Maher ER, Chew SL.
    Endocr Relat Cancer; 2009 Jun 11; 16(2):515-25. PubMed ID: 19208735
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
    Klein RD, Jin L, Rumilla K, Young WF, Lloyd RV.
    Diagn Mol Pathol; 2008 Jun 11; 17(2):94-100. PubMed ID: 18382370
    [Abstract] [Full Text] [Related]

  • 36. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH, Dwight T, Benn DE, Meyer-Rochow GY, Gill AJ, Sywak M, Sidhu S, Veivers D, Sue CM, Robinson BG, Clifton-Bligh RJ, Parker NR.
    Endocr Relat Cancer; 2014 Jun 11; 21(3):415-26. PubMed ID: 24623741
    [Abstract] [Full Text] [Related]

  • 37. Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas.
    López-Jiménez E, Gómez-López G, Leandro-García LJ, Muñoz I, Schiavi F, Montero-Conde C, de Cubas AA, Ramires R, Landa I, Leskelä S, Maliszewska A, Inglada-Pérez L, de la Vega L, Rodríguez-Antona C, Letón R, Bernal C, de Campos JM, Diez-Tascón C, Fraga MF, Boullosa C, Pisano DG, Opocher G, Robledo M, Cascón A.
    Mol Endocrinol; 2010 Dec 11; 24(12):2382-91. PubMed ID: 20980436
    [Abstract] [Full Text] [Related]

  • 38. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma.
    Cascon A, Ruiz-Llorente S, Cebrian A, Telleria D, Rivero JC, Diez JJ, Lopez-Ibarra PJ, Jaunsolo MA, Benitez J, Robledo M.
    Eur J Hum Genet; 2002 Aug 11; 10(8):457-61. PubMed ID: 12111639
    [Abstract] [Full Text] [Related]

  • 39. Familial pheochromocytoma.
    Erlic Z, Neumann HP.
    Hormones (Athens); 2009 Aug 11; 8(1):29-38. PubMed ID: 19269919
    [Abstract] [Full Text] [Related]

  • 40. Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.
    Shankavaram U, Fliedner SM, Elkahloun AG, Barb JJ, Munson PJ, Huynh TT, Matro JC, Turkova H, Linehan WM, Timmers HJ, Tischler AS, Powers JF, de Krijger R, Baysal BE, Takacova M, Pastorekova S, Gius D, Lehnert H, Camphausen K, Pacak K.
    Neoplasia; 2013 Apr 11; 15(4):435-47. PubMed ID: 23555188
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.